R/C TIOTROPIN 3D:Uses, Side Effects, Dosage & More....

R/C TIOTROPIN 3D

Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg)

R/C TIOTROPIN 3D combination of Ciclesonide (400mcg), Formoterol (12mcg), and Tiotropium (18mcg), marketed as R/C Tiotropin 3D. Explore its components, mechanism of action, uses, dosage, benefits, and potential side effects.

Understanding the Components

• Ciclesonide (400mcg): A corticosteroid that reduces inflammation in the airways, preventing asthma attacks and COPD exacerbations.
• Formoterol (12mcg): A long-acting beta agonist that relaxes bronchial muscles, improving airflow and reducing symptoms like wheezing and shortness of breath.
• Tiotropium (18mcg): An anticholinergic bronchodilator that widens air passages, making breathing easier for individuals with COPD.

Mechanism of Action

• Ciclesonide reduces airway inflammation by inhibiting the release of inflammatory mediators.
• Formoterol stimulates beta receptors in the lungs, leading to bronchodilation and improved airflow.
• Tiotropium blocks muscarinic receptors, relaxing smooth muscles in the airways and reducing bronchoconstriction.

Uses and Indications

• Asthma Management: This combination inhaler is effective in controlling asthma symptoms, reducing the frequency of asthma attacks, and improving lung function.
• COPD Treatment: It is also prescribed for COPD patients to manage symptoms like coughing, shortness of breath, and exercise intolerance.

Dosage Guidelines

• The recommended dosage typically involves inhaling one puff from the inhaler device once or twice daily, as directed by a healthcare professional.
• It is essential to follow the prescribed regimen for optimal therapeutic effects.

Benefits of Combination Therapy

• Comprehensive Treatment: Combining Ciclesonide, Formoterol, and Tiotropium provides a comprehensive approach to managing respiratory conditions, targeting inflammation, bronchoconstriction, and airflow limitation.
• Symptom Control: Patients often experience improved symptom control, reduced rescue medication use, and enhanced quality of life with this combination therapy.

Potential Side Effects

• Common side effects may include throat irritation, dry mouth, headache, or hoarseness.
• Rare but serious side effects such as allergic reactions or cardiovascular effects should be reported to a healthcare provider promptly.

Conclusion

The combination inhaler containing Ciclesonide (400mcg), Formoterol (12mcg), and Tiotropium (18mcg), known as R/C Tiotropin 3D, is an effective treatment option for asthma and COPD. Its comprehensive approach, addressing inflammation and bronchospasm, makes it a valuable tool in improving respiratory health and enhancing patient well-being.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW